Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors
US12291516B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2020 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Jul 21, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a compound of formula I or a pharmaceutically acceptable salt, active metabolite, tautomer, stereoisomer, or prodrug thereof as BTK (Bruton's Tyrosine Kinase) inhibitors, which is useful for the treatment of autoimmune disease, inflammatory disease, cancer and potentially allergies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.